9-[N-gamma-(2'-(nitrooxy)acetyl)-gamma-aminopropylamino]-1,2,3,4-tetrahydroacridine

ID: ALA269865

Chembl Id: CHEMBL269865

PubChem CID: 24800130

Max Phase: Preclinical

Molecular Formula: C18H22N4O4

Molecular Weight: 358.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CO[N+](=O)[O-])NCCCNc1c2c(nc3ccccc13)CCCC2

Standard InChI:  InChI=1S/C18H22N4O4/c23-17(12-26-22(24)25)19-10-5-11-20-18-13-6-1-3-8-15(13)21-16-9-4-2-7-14(16)18/h1,3,6,8H,2,4-5,7,9-12H2,(H,19,23)(H,20,21)

Standard InChI Key:  FWBFWRIDEUVUDF-UHFFFAOYSA-N

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Artery (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Butyrylcholinesterase (805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 358.40Molecular Weight (Monoisotopic): 358.1641AlogP: 2.24#Rotatable Bonds: 8
Polar Surface Area: 106.39Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.89CX LogP: 1.89CX LogD: 0.56
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.43Np Likeness Score: -1.18

References

1. Fang L, Appenroth D, Decker M, Kiehntopf M, Roegler C, Deufel T, Fleck C, Peng S, Zhang Y, Lehmann J..  (2008)  Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates.,  51  (4): [PMID:18232655] [10.1021/jm701491k]
2. Fang L, Appenroth D, Decker M, Kiehntopf M, Lupp A, Peng S, Fleck C, Zhang Y, Lehmann J..  (2008)  NO-donating tacrine hybrid compounds improve scopolamine-induced cognition impairment and show less hepatotoxicity.,  51  (24): [PMID:19053746] [10.1021/jm801131a]

Source